The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

Cliradoe     1-[4-(3-hydroxyphenyl)-1- methyl-4...

Synonyms: Cliradon, Cliradone, Cymidoe, Cymidon, Ketodur, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Cymidon

 

High impact information on Cymidon

 

Chemical compound and disease context of Cymidon

 

Biological context of Cymidon

 

Anatomical context of Cymidon

  • The first group received intramuscular narcotic analgesic ketobemidone, the second group was given 0.5% bupivacaine-epinephrine intercostal nerve block, and the third group received a single dose of 4 mg of epidural morphine for postoperative pain relief [16].
  • The highest observed concentration of ketobemidone in breast milk was 36 ng/ml three hours after administration, and 4-7 hours after administration the concentration was 3-5 fold that in maternal plasma [17].
  • If pain relief was not adequate, the infusion rate was doubled, and if this was still not sufficient, 5 mg injections of ketobemidone were given i.v. If the orotracheal tube was not tolerated, the internal branch of the superior laryngeal nerve was blocked [18].
  • METHODS: Forty-eight patients randomly received PCA or NCA with ketobemidone following extubation after coronary artery bypass grafting [13].
  • In Group I blood loss was replaced with microaggregate-poor erythrocyte concentrate (SAGM-ERC) plus 3% dextran-60 as plasma substitute, and postoperative analgesia was maintained with intramuscular ketobemidone [19].
 

Associations of Cymidon with other chemical compounds

 

Gene context of Cymidon

 

Analytical, diagnostic and therapeutic context of Cymidon

References

  1. Patient-controlled analgesic therapy, Part III: pharmacokinetics and analgesic plasma concentrations of ketobemidone. Tamsen, A., Bondesson, U., Dahlström, B., Hartvig, P. Clinical pharmacokinetics. (1982) [Pubmed]
  2. Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with other opioid agonists. Sjøgren, P., Jensen, N.H., Jensen, T.S. Pain (1994) [Pubmed]
  3. The pharmacokinetics of ketobemidone in critically ill patients. Al-Shurbaji, A., Tokics, L. British journal of clinical pharmacology. (2002) [Pubmed]
  4. Laparoscopic occlusion compared with embolization of uterine vessels: a randomized controlled trial. Hald, K., Kl??w, N.E., Qvigstad, E., Istre, O. Obstetrics and gynecology (2007) [Pubmed]
  5. The opioid ketobemidone has a NMDA blocking effect. Andersen, S., Dickenson, A.H., Kohn, M., Reeve, A., Rahman, W., Ebert, B. Pain (1996) [Pubmed]
  6. Regular interval preventive pain relief compared with on demand treatment after hysterectomy. Jørgensen, B.C., Schmidt, J.F., Risbo, A., Pedersen, J., Kolby, P. Pain (1985) [Pubmed]
  7. Conformation-activity study of 4-phenylpiperidine analgesics. Froimowitz, M. J. Med. Chem. (1982) [Pubmed]
  8. Ketobemidone may alter busulfan pharmacokinetics during high-dose therapy. Hassan, M., Svensson, J.O., Nilsson, C., Hentschke, P., Al-Shurbaji, A., Aschan, J., Ljungman, P., Ringdén, O. Therapeutic drug monitoring. (2000) [Pubmed]
  9. A comparison between morphine, meperidine and ketobemidone in continuous intravenous infusion for postoperative relief. Ohqvist, G., Hallin, R., Gelinder, S., Lang, H., Samuelson, S. Acta anaesthesiologica Scandinavica. (1991) [Pubmed]
  10. High frequency of cough after intravenous bolus injection of Ketogan (ketobemidone + N,N-dimethyl-3,3-diphenyl-1-methylallylamine chloride) for postoperative pain relief. Karlsten, R., Hartvig, P. Acta anaesthesiologica Scandinavica. (1992) [Pubmed]
  11. Wound infiltration with ropivacaine and fentanyl: effects on postoperative pain and PONV after breast surgery. Johansson, A., Kornfält, J., Nordin, L., Svensson, L., Ingvar, C., Lundberg, J. Journal of clinical anesthesia. (2003) [Pubmed]
  12. Clinical pharmacokinetics of ketobemidone. Its bioavailability after rectal administration. Anderson, P., Arnér, S., Bondesson, U., Boréus, L.O., Hartvig, P. Eur. J. Clin. Pharmacol. (1981) [Pubmed]
  13. Patient-controlled versus nurse-controlled pain treatment after coronary artery bypass surgery. Pettersson, P.H., Lindskog, E.A., Owall, A. Acta anaesthesiologica Scandinavica. (2000) [Pubmed]
  14. The pharmacokinetics of ketobemidone are not affected by CYP2D6 or CYP2C19 phenotype. Al-Shurbaji, A., Säwe, J. Eur. J. Clin. Pharmacol. (2002) [Pubmed]
  15. Multiple dose kinetics of ketobemidone in surgical patients. Bondesson, U., Tamsen, A., Dahlström, B., Hartvig, P. Acta anaesthesiologica Scandinavica. Supplementum. (1982) [Pubmed]
  16. Epidural morphine for postoperative pain relief: a comparative study with intramuscular narcotic and intercostal nerve block. Rawal, N., Sjöstrand, U.H., Dahlström, B., Nydahl, P.A., Ostelius, J. Anesth. Analg. (1982) [Pubmed]
  17. Excretion of ketobemidone in human breast milk. Gerdin, E., Bondesson, U., Hartvig, P. Journal of perinatal medicine. (1996) [Pubmed]
  18. Low-dose ketamine infusion for analgesia during postoperative ventilator treatment. Joachimsson, P.O., Hedstrand, U., Eklund, A. Acta anaesthesiologica Scandinavica. (1986) [Pubmed]
  19. Blood substitution and complement activation. Schött, U., Berséus, O., Järemo, P. Acta anaesthesiologica Scandinavica. (1987) [Pubmed]
  20. Ketobemidone, methadone and pethidine are non-competitive N-methyl-D-aspartate (NMDA) antagonists in the rat cortex and spinal cord. Ebert, B., Andersen, S., Krogsgaard-Larsen, P. Neurosci. Lett. (1995) [Pubmed]
  21. Bioavailability and analgesic effect of sustained release cetobemidone capsules in cancer patients with chronic pain of malignant origin. Kjaer, M., Nielsen, H., Olsen, F.E., Andersen, L.S., Philipsen, J., Velander, G. Acta oncologica (Stockholm, Sweden) (1992) [Pubmed]
  22. Ketobemidone is a substrate for cytochrome P4502C9 and 3A4, but not for P-glycoprotein. Yasar, U., Annas, A., Svensson, J.O., Lazorova, L., Artursson, P., Al-Shurbaji, A. Xenobiotica (2005) [Pubmed]
  23. The use of NMDA-receptor antagonists in the treatment of chronic pain. Hewitt, D.J. The Clinical journal of pain. (2000) [Pubmed]
  24. Oral premedication one hour before minor gynaecological surgery--does it have any effect? A comparison between ketobemidone, lorazepam, propranolol and placebo. Jakobsson, J., Rane, K., Ryberg, G. Acta anaesthesiologica Scandinavica. (1995) [Pubmed]
  25. Ketobemidone plus (RS)-3-dimethylamino-1,1-diphenylbut-1-ene (A29) is more potent at NMDA receptors than ketobemidone alone: evidence for A29 as a non-competitive NMDA receptor antagonist. Ebert, B., Thorkildsen, C., Andersen, S. Pharmacol. Toxicol. (1998) [Pubmed]
  26. Postoperative pain after abdominal hysterectomy: a double-blind comparison between placebo and local anesthetic infused intraperitoneally. Gupta, A., Perniola, A., Axelsson, K., Thörn, S.E., Crafoord, K., Rawal, N. Anesth. Analg. (2004) [Pubmed]
  27. Quantitative determination of the urinary excretion of ketobemidone and four of its metabolites after intravenous and oral administration in man. Bondesson, U., Hartvig, P., Danielsson, B. Drug Metab. Dispos. (1981) [Pubmed]
  28. Extradural block in patients who have previously undergone caesarean section. Carlsson, C., Nybell-Lindahl, G., Ingemarsson, I. British journal of anaesthesia. (1980) [Pubmed]
 
WikiGenes - Universities